Physician profile
Charles Lieu
NPI 1871510396
$872.53
in general payments reported to CMS, 2019-2025
9 companies · $72.90 in 2025
The $72.90 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $115 · 2021: $152 · 2022: $98.94 · 2023: $136 · 2024: $188 · 2025: $72.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $541.84 | 2019-2024 | |
| Glaxosmithkline, LLC. | $165.83 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Abbott Laboratories | $46.89 | 2024-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $24.41 | 2019 | |
| Harmony Biosciences LLC | $22.20 | 2024 | |
| Amgen INC. | $20.73 | 2024 | Repatha, Otezla |
| Exact Sciences Corporation | $20.11 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $15.76 | 2025 | Wegovy |
| Recor Medical INC | $14.76 | 2024 | Paradise Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.